Research Reports
Neurodiagnostics Marketworth USD 9050.7 Million by 2025, registering a CAGR of 8.1%
“Neurodiagnostics Marketis valued at USD 5246.9 Million in 2018 and expected to reach USD 9050.7 Million by 2025 with the CAGR of 8.1% over the forecast period.”Increasing prevalence of neurological
Published : 3 years ago, on
“Neurodiagnostics Marketis valued at USD 5246.9 Million in 2018 and expected to reach USD 9050.7 Million by 2025 with the CAGR of 8.1% over the forecast period.”
Increasing prevalence of neurological disorders and growing number of diagnostic centers & hospitals are the major factors driving the growth of global neurodiagnostics market.
Get Sample Report:@https://brandessenceresearch.com/requestSample/PostId/986
Scope of Global Neurodiagnostics Market Report-
Neurodiagnostics is associated with health care profession that monitors, records and analyzes nervous system function to help the effective treatment of pathologic conditions. It is a technique employed by technologists to record electrical activity arising from the brain, medulla spinalis, and peripheral nerves employing a sort of techniques and instruments. It is used in preparing patients for procedures, obtaining medical histories, recording electrical potentials, calculating results, and maintaining equipment. Neurodiagnostics is a field of science devoted to recording and studying the electrical activity of the brain and nervous system. This activity is recorded using the various procedures such as electroencephalogram (EEG), nerve conduction study (NCS), electroencephalogram (EEG) and evoked potentials (EP). It is utilized in diagnosis of neurological disorders or neurological diseases. In fact, neurological disorders are increasingly recognized as major causes of death and disability around worldwide.
Global Neurodiagnostics market report is segmented on the basis of product, disease type, end-user and by regional & country level. Based on application, global Neurodiagnostics market is classified into diagnostic & imaging systems (MRI, Ultrasound), clinical testing (PCR, NGS) and reagents & consumables. Based upon disease type, global neurodiagnostics market is classified into Alzheimer’s disease, migraine, Parkinson’s disease, epilepsy, stroke, multiple sclerosis, neurodegeneration and others. Based upon end-user, global neurodiagnostics market is classified into operation theatres, hospitals, clinics and neurophysiological laboratories.
The regions covered in this Neurodiagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Neurodiagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Neurodiagnostics Companies:
Neurodiagnostics market report covers prominent players,
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Hitachi, Ltd
- Canon, Inc.
- Lifelines Neuro Company, LLC
- Natus Medical Incorporated
- Hoffman-La Roche AG
- FUJIFILM Holdings Corporation
- Mitsar Co., Ltd.
- Advanced Brain Monitoring
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories
- QIAGEN N.V.
- Nihon Kohden Corporation
- ANT Neuro
- Fonar Corporation
- Fujirebio
- DRG Instruments GmbH
- Tecan Trading AG
- Motion Lab Systems, Inc.
- Rigaku Corporation
- Neusoft Medical Systems Co., Ltd.
- ELMIKO MEDICAL Sp. Z o.o.
- Ridge Diagnostics
- Others
Global Neurodiagnostics MarketDynamics-
Increasing prevalence of neurological disorders, growing number of diagnostic centers & hospitals, growing importance on effective & early disease diagnosis and the use of biomarker profiling for disease diagnostics are the major factors drive the growth of global neurodiagnostics market. In addition, rising patient population of neurological disorders across the globe will also boost the neurodiagnostics market growth within the forecast period. According to World Health Organization, around 50 million people have dementia across globe and there are nearly 10 million new cases every year. Furthermore, increasing advancements in diagnostic equipments and growing use of imaging techniques in drug development are also supplementing the market growth. Growing aging-related neurological diseases such as stroke, Alzheimer’s disease, Parkinson’s disease, and dementia are also augmenting the market growth. According to a report by the Alzheimer’s Association; more than 5 million Americans are living with alzheimer’s and this number is projected to rise to nearly 14 million by 2050. However, lack of skilled workers and limitations of EEGs in providing accurate diagnosis may hamper the growth of the market. In spite of that, technologically advanced diagnostic platforms in the healthcare sectors may generate new opportunities for the further growth of the market.
Global Neurodiagnostics MarketRegional Analysis-
North America is expected to dominate the global neurodiagnostics market with the potential rate due to the high investments in R&D in healthcare, growing adoption of innovative technologies, rising incidence of neurological diseases and presence of leading players in the region. According to a report by the Alzheimer’s association; Alzheimer’s disease is the 6th leading cause of death in the United States. As per U.S College of Pharmacy & Health Sciences; 20 million Americans experience some form of neuropathy, and 16% of U.S. households contain an individual with brain impairment.
Europe is expected to capture the second lead in the global neurodiagnostics market due to the increasing geriatric population which is more prone to different neurological disorders such as stroke, Alzheimer’s disease, Parkinson’s disease, autism and dementia. According to The National Autistic Society, around 700,000 people on the autism spectrum in the U.K. in 2018.
The Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period due to the rising healthcare expenditure and growing population in countries like India and China. In addition, increasing advancements in research development in this region is also supplementing the market growth. According to Organisation for Economic Co-operation and Development(OECD); in high income Asia-Pacific countries, the share of population aged over 65 years is expected to double to reach and on average 27.6% in 2050, whereas the share of population aged over 80 years is expected to triple between 2015-2050 to reach 10.2%.
Key Benefits for GlobalNeurodiagnostics MarketReport-
- Global Market report covers in depth historical and forecast analysis.
- Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Market report helps to identify opportunities in market place.
- Global Market report covers extensive analysis of emerging trends and competitive landscape.
Global Neurodiagnostics MarketSegmentation:-
By Product:
- Diagnostic & Imaging Systems
- MRI
- Ultrasound
- Clinical Testing
- PCR
- NGS
- Reagents & Consumables
By Disease Type:
- Alzheimer’s Disease
- Migraine
- Parkinson’s Disease
- Epilepsy
- Stroke
- Multiple sclerosis
- Neurodegeneration
- Others
By End-User:
- Operation Theatres
- Hospitals
- Clinics
- Neurophysiological Laboratories
Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2019?
- How will each segment grow over the forecast period and how much revenue will these segment account for in 2027?
- Which region has more opportunities?
Get Full Report: @https://brandessenceresearch.com/healthcare/neurodiagnostics-market-size
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at[email protected]
-
Business4 days ago
Britain’s Tesco lifts profit outlook after strong first half
-
Top Stories4 days ago
SWIFT to trial live digital currency transactions next year
-
Business4 days ago
Exclusive-Online retailer Shein to hold roadshows soon ahead of London IPO, sources say
-
Top Stories4 days ago
Levi Strauss shares fall on weak holiday-quarter forecast